Efficient Funding of Chemotherapy – Summary of Changes 1 May 2012

Efficient Funding of Chemotherapy – Summary of Changes 1 May 2012

Additions

Additions – Brands

4433H, 7244G

Bleomycin Sulfate

Injection

Bleo 15K, WQ (Powder for injection 15,000 i.u.)

4364Q, 7230M

Doxorubicin Hydrochloride,
Pegylated Liposomal

Injection

Lipodox, ZF (Suspension for I.V. infusion 20 mg in 10 mL)

4364Q, 7230M

Doxorubicin Hydrochloride,
Pegylated Liposomal

Injection

Lipodox 50, ZF (Suspension for I.V. infusion 50 mg in 25 mL)

 

Deletions

Deletions – Items

4402Q, 7235T

Bleomycin Sulfate

Injection

Powder for injection 15,000 i.u. (Bleo 15K, WQ)

Note: A Special Patient Contribution has been applied to ‘Bleo 15K’. This brand is now listed under items 4433H and 7244G (see above).

 

Deletions – Brands

4309T, 7222D

Carboplatin

Injection

Pfizer Australia Pty Ltd, PF (Solution for I.V. injection 50 mg in 5 mL)

4319H, 7224F

Cisplatin

Injection

Pfizer Australia Pty Ltd, PF (I.V. injection 10 mg in 10 mL)

4361M, 7229L

Doxorubicin
Hydrochloride

 

Injection/
intravesical

 

Adriamycin Solution, PF (Solution for I.V. injection or
intravesical administration 10 mg in 5 mL)

4361M, 7229L

Doxorubicin
Hydrochloride

Injection/
intravesical

Adriamycin Solution, PF (Solution for I.V. injection or
intravesical administration 20 mg in 10 mL)

4375G, 7231N

Epirubicin Hydrochloride

Injection/
intravesical

Pharmorubicin Solution, PF (Solution for injection 10 mg in 5 mL)

4375G, 7231N

Epirubicin Hydrochloride

Injection/
intravesical

Pharmorubicin Solution, PF (Solution for injection 20 mg in 10 mL)

4451G, 7249M

Irinotecan Hydrochloride
Trihydrate

Injection

Camptosar, PF (I.V. injection 40 mg in 2 mL)

4514N, 7252Q

Mitozantrone
Hydrochloride

Injection

Pfizer Australia Pty Ltd, PF (Injection 10 mg (base) in 5 mL)

4514N, 7252Q

Mitozantrone
Hydrochloride

Injection

Pfizer Australia Pty Ltd, PF (Injection 25 mg (base) in 12.5 mL)

4542C, 7253R

Oxaliplatin

Injection

Winthrop Oxaliplatin, WA (Powder for I.V. infusion 100 mg)

4619D, 7262F

Vincristine Sulfate

Injection

Pfizer Australia Pty Ltd, PF (I.V. injection 1 mg in 1 mL)

  

Deletion – Equivalence Indicator

4619D, 7262F

Vincristine Sulfate

Injection

Hospira Pty Limited, HH (I.V. injection 1 mg in 1 mL)